Free Trial
OTCMKTS:INBP

Integrated BioPharma (INBP) Stock Price, News & Analysis

Integrated BioPharma logo
$0.19 +0.00 (+2.16%)
As of 10/9/2026 11:40 AM Eastern

About Integrated BioPharma Stock (OTCMKTS:INBP)

Advanced

Key Stats

Today's Range
$0.18
▼
$0.19
50-Day Range
$0.15
▼
$0.19
52-Week Range
$0.14
▼
$0.42
Volume
5,100 shs
Average Volume
19,916 shs
Market Capitalization
$5.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Integrated BioPharma, Inc. (OTCMKTS:INBP) is a healthcare products company engaged in the manufacture and distribution of vitamins, nutritional supplements, herbal products, and pharmaceutical products. Its activities are focused on products intended to support general health and wellness.

The company has historically served the U.S. market through a combination of proprietary products, contract manufacturing, and wholesale distribution activities. Its manufacturing capabilities have included a range of product formats, such as capsules, tablets, softgels, liquids, powders, creams, and lotions, depending on customer and product requirements.

Integrated BioPharma’s operations have included the development, production, and distribution of health-related consumer products for its own brands and other businesses. Publicly available information about its current leadership structure, product portfolio, and geographic reach is limited.

AI Generated. May Contain Errors.

Receive INBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INBP Stock News Headlines

Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Integrated BioPharma Holds 2025 Annual Stockholder Meeting
INBP Integrated BioPharma, Inc.
Integrated Biopharma Inc (INBP)
See More Headlines

INBP Stock Analysis - Frequently Asked Questions

Integrated BioPharma's stock was trading at $0.3550 at the start of the year. Since then, INBP shares have decreased by 46.8% and is now trading at $0.1890.

Integrated BioPharma Inc. (OTCMKTS:INBP) released its quarterly earnings results on Friday, September, 25th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $9.80 million for the quarter. Integrated BioPharma had a negative trailing twelve-month return on equity of 14.78% and a negative net margin of 6.48%.

Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated BioPharma investors own include GSK (GSK), Invitae (NVTA), ExxonMobil (XOM), Autodesk (ADSK), Adaptive Biotechnologies (ADPT), Analog Devices (ADI) and Adaptimmune Therapeutics (ADAP).

Company Calendar

Last Earnings
9/25/2026
Today
10/11/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:INBP
CIK
1016504
Employees
150
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.84 million
Net Margins
-6.48%
Pretax Margin
-5.84%
Return on Equity
-14.78%
Return on Assets
-11.24%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.00
Quick Ratio
1.42

Sales & Book Value

Annual Sales
$43.87 million
Price / Sales
0.13
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
0.33

Miscellaneous

Outstanding Shares
30,980,000
Free Float
10,098,000
Market Cap
$5.86 million
Optionable
Not Optionable
Beta
0.50

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:INBP) was last updated on 10/11/2026 by MarketBeat.com Staff.
From Our Partners